ImmunologyCell ReportsPeer-reviewed
Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune-checkpoint inhibitors
Francesco Ravera, Martina Dameri, Isabella Lombardo…·Gabriele M. Zoppoli
This study examines how rituximab and immune-checkpoint inhibitors affect immune responses to a COVID-19 booster vaccine, finding rituximab impairs interferon response and ICI maintains normal immune profiles.
5 citations